The trading price of Resmed Inc. (NYSE:RMD) floating higher at last check on current market day and closing at $238.86, 5.76% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $226.82 and $241.0. The company’s P/E ratio in the trailing 12-month period was 34.51, while its 5Y monthly beta was 0.664. In examining the 52-week price action we see that the stock hit a 52-week high of $231.50 and a 52-week low of $132.24. Over the past month, the stock has gained 14.54% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Resmed Inc., whose market valuation is $35.10 billion at the time of this writing, is expected to release its quarterly earnings report in September. The dividend yield on the company stock is 0.82%, while its Forward Dividend ratio is 1.97. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest RMD has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned RMD a recommendation rating is 19. Out of them, 8 rate it a Hold, while 10 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Resmed Inc. (RMD) as Underweight, while 1 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 2.23, which symbolizes a positive outlook. A quick review shows that RMD’s price is currently 8.51% off the SMA20 and 14.90% off the SMA50. The RSI metric on the 14-day chart is currently showing 68.21, and weekly volatility stands at 2.14%. When measured over the past 30 days, the indicator reaches 3.15%. Resmed Inc. (NYSE:RMD)’s beta value is currently sitting at 0.68, while the Average True Range indicator is currently displaying 6.67. With analysts defining $175-$250 as the low and high price targets, we arrive at a consensus price target of $205.5 for the trailing 12-month period. The current price is about 26.74% off the estimated low and -4.66% off the forecast high, based on this estimate. Investors will be thrilled if RMD’s share price rises to $205.5, which is the median consensus price. At that level, RMD’s share price would be 13.97% above current price.
To see how Resmed Inc. stock has been performing today in comparison to its peers in the industry, here are the numbers: RMD stock’s performance was 5.76% at last check in today’s session, and 48.38% in the past year. Resmed Inc. has a P/E ratio of 34.51.
An evaluation of the daily trading volume of Resmed Inc. (NYSE:RMD) indicates that the 3-month average is 1.08 million. However, this figure has increased over the past 10 days to an average of 0.78.
Currently, records show that 146.90 million of the company’s shares remain outstanding. The insiders hold 0.81% of outstanding shares, whereas institutions hold 60.97%. The stats also highlight that short interest as of 2024-07-31, stood at 8.9 million shares, resulting in a short ratio of 10.27 at that time. From this, we can conclude that short interest is 691.00 of the company’s total outstanding shares. It is noteworthy that short shares in July were up slightly from the previous month’s figure, which was 8.58 million. However, since the stock’s price has seen 38.86% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
